Are you kidding?

Are you kidding?

“These results increase the body of evidence on the use of Toujeo in people with Type II diabetes from observational studies. While randomized clinical trials provide the highest level of evidence, comparative data from real-world observational studies can be relevant for payors and other organizations evaluating how findings from clinical trials can translate into routine clinical practice. Sanofi is committed to going beyond traditional models to conduct further studies to assess Toujeo, combining the broad populations, and type of interaction between healthcare professionals and patients seen in routine care with the rigorous methodology of clinical trials. The randomized Real . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.